Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions
AssigneeBoehringer Ingelheim International GmbH
InventorRaul Altman
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoehringer Ingelheim International GmbH
InventorRaul Altman
Estimating the term…
The invention relates to a method of treatment or prevention of acute coronary syndrome or related conditions or reducing the risk of cardiovascular events comprising the administration of a therapeutically or prophylactically effective amount of meloxicam in combination with a therapeutically or prophylactically effective amount of an antiplatelet agent to a patient in need of such treatment. The invention also provides pharmaceutical compositions comprising meloxicam and an antiplatelet agent as a combined preparation suitable for use in these indications. Furthermore, the invention provides the use of meloxicam for manufacture of a pharmaceutical composition for treatment or prevention of acute coronary syndrome and related conditions when used in combination with an antiplatelet agent.
A method for the treatment or prevention of acute coronary syndrome or a related condition or reducing the risk of a cardiovascular event comprising the administration of a therapeutically or prophylactically effective amount of meloxicam in combination with a therapeutically or prophylactically effective amount of an antiplatelet agent to a patient in need of such treatment.
A pharmaceutical composition comprising a therapeutically or prophylactically effective amount of meloxicam and a therapeutically or prophylactically effective amount of an antiplatelet agent.
Dependencies are inferred from the claim text.